Presented at the SYNChronicity Conference.
Presented at the SYNChronicity Conference by the Hepatic Innovation Team Collaborative Leadership Team of the Veterans Health Administration.
Presented at the SYNChronicity Conference.
This presentation examines the development of a microelimination plan.
Presented at the SYNChronicity Conference.
The Implementing Transmucosal Buprenorphine for Treatment of Opioid Use Disorder best practice document was designed to fill information gaps and provide guidance.
Presented at the SYNChronicity Conference, developed by the Hepatitis C Mentoring and Support Group (HCMSG).
This presentation from the SYNChronicity conference examines the effects of opioid use on HCV.
This recording of a presentation by CDC’s Dr. Sarah Schillie explores CDC’s newest HCV screening recommendations.
Learn more about model practices for increasing HCV screening and linkage to care in a variety of practice settings.